Annex I. Article 31 of Directive 2001/83/EC. Procedure number: EMEA/H/A-31/1448
|
|
|
- Berenice Welch
- 9 years ago
- Views:
Transcription
1 8 July 2016 EMA/472578/20166 Procedure Management and Committees Support Division List of the names, pharmaceutical s, strengths of the medicinal products, routes of, marketing authorisation s in the member states for human and recombinant coagulation factor VIII containing medicinal products Article 31 of Directive 2001/83/EC Procedure number: EMEA/H/A-31/1448 Advate EMEA/H/C/0520/A31/0078 Elocta EMEA/H/C/3964/A31/0006 Helixate Nexgen EMEA/H/C/0276/A31/0178 Iblias EMEA/H/C/4147/A31/0002 Kogenate EMEA/H/C/0275/A31/0185 Kovaltry EMEA/H/C/3825/A31/0004 Novoeight EMEA/H/C/2719/A31/0014 Nuwiq EMEA/H/C/2813/A31/0015 Obizur EMEA/H/C/2792/A31/0003 Refacto AF EMEA/H/C/0232/A31/0134 Voncento EMEA/H/C/2493/A31/ Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0) Facsimile +44 (0) Send a question via our website An agency of the European Union European Medicines Agency, Reproduction is authorised provided the source is acknowledged.
2 Nationally authorised products Member State in Austria Immunate Baxter Ag, Von Factor 100 I.U. /, Von Factor 75 I.U. / Austria Immunate Baxter Ag, Von Factor 50 I.U. /, Von Factor 38 I.U. / Austria Optivate Bio Products Laboratory 100 I.U. / Austria Haemoctin Sdh Biotest Austria 100 I.U. / Austria Haemoctin Sdh Biotest Austria EMA/472578/2016 Page 2/124
3 50 I.U. / Austria Beriate Csl Behring 100 I.U. / /Infusion Austria Beriate Csl Behring 200 I.U. / /Infusion Austria Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion Austria Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Austria Octanate Octapharma Pharmazeutika EMA/472578/2016 Page 3/124
4 Produktionsgesmbh 1000 Austria Octanate Octapharma Pharmazeutika Produktionsgesmbh 250 Austria Octanate Octapharma Pharmazeutika Produktionsgesmbh 500 Austria Octanate Lv Octapharma Pharmazeutika Produktionsgesmbh 1000 Austria Octanate Lv Octapharma Pharmazeutika Produktionsgesmbh 500 Austria Wilate Octapharma Pharmazeutika, Von Produktionsgesmbh Factor 1000, Von Factor 1000 Austria Wilate Octapharma Pharmazeutika, Von EMA/472578/2016 Page 4/124
5 Produktionsgesmbh Factor 450, Von Factor 400 I.U. Vial Austria Wilate Octapharma Pharmazeutika Produktionsgesmbh, Von Factor 500, Von Factor 500 I.U. Vial Austria Wilate Octapharma Pharmazeutika Produktionsgesmbh, Von Factor 900, Von Factor 800 I.U. Vial Belgium Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Belgium Recombinate Baxalta Innovations EMA/472578/2016 Page 5/124
6 (Rdna) (Rdna) 200 I.U. / Belgium Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Belgium Optivate Bio Products Laboratory 100 I.U. / Belgium Factane Cafdcf, Von Factor 100 I.U. /, Von Factor 20 I.U. / Belgium Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. /Infusion EMA/472578/2016 Page 6/124
7 / Belgium Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Belgium Octanate Octapharma Benelux S.A./N.V Belgium Octanate Octapharma Benelux S.A./N.V. 250 Belgium Octanate Octapharma Benelux S.A./N.V. 500 Belgium Wilate Octapharma Benelux S.A./N.V., Von Factor 1000, Von Factor 1000 EMA/472578/2016 Page 7/124
8 Belgium Wilate Octapharma Benelux S.A./N.V., Von Factor 500, Von Factor 500 I.U. Vial Bulgaria рекомбинейт Baxter Ag (Rdna) (Rdna) 100 I.U. / Bulgaria рекомбинейт Baxter Ag (Rdna) (Rdna) 200 I.U. / Bulgaria рекомбинейт Baxter Ag (Rdna) (Rdna) 50 I.U. / Bulgaria хемоктин Biotest Pharma 100 I.U. / EMA/472578/2016 Page 8/124
9 Bulgaria хемоктин Biotest Pharma 50 I.U. / Bulgaria бериате Csl Behring 100 I.U. / /Infusion Bulgaria бериате Csl Behring 200 I.U. / /Infusion Bulgaria фанди Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 120 I.U. / Bulgaria фанди Instituto Grifols, S.A., Von Factor 25 I.U. /, Von Factor 30 I.U. / EMA/472578/2016 Page 9/124
10 Bulgaria фанди Instituto Grifols, S.A., Von Factor 50 I.U. /, Von Factor 60 I.U. / Bulgaria Emoclot Kedrion S.P.A. 500 I.U. / 10 Infusion Bulgaria Octanate Octapharma (Ip) Bulgaria Octanate Octapharma (Ip)- 500 Bulgaria Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 EMA/472578/2016 Page 10/124
11 Bulgaria Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Croatia Immunate Agmar D.O.O., Von Factor 100 I.U. /, Von Factor 75 I.U. / Croatia Recombinate Agmar D.O.O. (Rdna) (Rdna) 100 I.U. / Croatia Recombinate Agmar D.O.O. (Rdna) (Rdna) 25 I.U. / Croatia Recombinate Agmar D.O.O. (Rdna) EMA/472578/2016 Page 11/124
12 (Rdna) 50 I.U. / Croatia Fanhdi Biognost D.O.O. 100 I.U. / Croatia Fanhdi Biognost D.O.O. 25 I.U. / Croatia Fanhdi Biognost D.O.O. 50 I.U. / Croatia Fanhdi Biognost D.O.O., Von Factor 100 I.U. /, Von Factor 120 I.U. / Croatia Fanhdi Biognost D.O.O., Von Factor 25 I.U. /, Von EMA/472578/2016 Page 12/124
13 Factor 60 I.U. / Croatia Fanhdi Biognost D.O.O., Von Factor 50 I.U. /, Von Factor 60 I.U. / Croatia Beriate Csl Behring 100 I.U. / /Infusion Croatia Beriate Csl Behring 200 I.U. / /Infusion Croatia Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion Croatia Octanate Jana Pharm D.O.O. EMA/472578/2016 Page 13/124
14 1000 Croatia Octanate Jana Pharm D.O.O. 250 Croatia Octanate Jana Pharm D.O.O. 500 Croatia Wilate Jana Pharm D.O.O., Von Factor 1000, Von Factor 1000 Croatia Wilate Jana Pharm D.O.O., Von Factor 500, Von Factor 500 I.U. Vial Croatia Emoclot Jasika D.O.O. EMA/472578/2016 Page 14/124
15 1000 I.U. / 10 Infusion Croatia Emoclot Jasika D.O.O. 500 I.U. / 10 Infusion Cyprus Immunate Baxter Hellas, Von Factor 100 I.U. /, Von Factor 75 I.U. / Cyprus Immunate Baxter Hellas, Von Factor 50 I.U. /, Von Factor 38 I.U. / Cyprus Recombinate Baxter Hellas (Rdna) (Rdna) 100 I.U. / EMA/472578/2016 Page 15/124
16 Cyprus Recombinate Baxter Hellas (Rdna) (Rdna) 25 I.U. / Cyprus Recombinate Baxter Hellas (Rdna) (Rdna) 50 I.U. / Cyprus Optivate Bio Products Laboratory 100 I.U. / Cyprus Dried Fraction, Type 8y Bio Products Bio Products Laboratory, Von Factor 25 I.U. /, Von Factor 26 I.U. / Powder For Solution For Cyprus Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von /Infusion EMA/472578/2016 Page 16/124
17 Factor 160 I.U. / Cyprus Octanate Octapharma (Ip) Cyprus Octanate Octapharma (Ip)- 250 Cyprus Octanate Octapharma (Ip)- 500 Cyprus Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 Cyprus Wilate Octapharma (Ip)-, Von Factor 450, Von EMA/472578/2016 Page 17/124
18 Factor 400 I.U. Vial Cyprus Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Cyprus Wilate Octapharma (Ip)-, Von Factor 900, Von Factor 800 I.U. Vial Czech Republic Immunate Stim Plus Baxter Ag, Von Factor 100 I.U. /, Von Factor 75 I.U. / Czech Republic Immunate Stim Plus Baxter Ag, Von EMA/472578/2016 Page 18/124
19 Factor 50 I.U. /, Von Factor 38 I.U. / Czech Republic Recombinate Baxter Ag (Rdna) (Rdna) 100 I.U. / Czech Republic Recombinate Baxter Ag (Rdna) (Rdna) 200 I.U. / Czech Republic Recombinate Baxter Ag (Rdna) (Rdna) 50 I.U. / Czech Republic Recombinate Baxter Czech Spol. S R.O. (Rdna) (Rdna) 100 I.U. / Czech Republic Recombinate Baxter Czech Spol. S R.O. (Rdna) EMA/472578/2016 Page 19/124
20 (Rdna) 200 I.U. / Czech Republic Recombinate Baxter Czech Spol. S R.O. (Rdna) (Rdna) 50 I.U. / Czech Republic Optivate Bio Products Laboratory 100 I.U. / Czech Republic Haemoctin Sdh Biotest Pharma 100 I.U. / Czech Republic Haemoctin Sdh Biotest Pharma 50 I.U. / Czech Republic Beriate Csl Behring 100 I.U. / /Infusion Czech Republic Beriate Csl Behring 200 I.U. / /Infusion EMA/472578/2016 Page 20/124
21 Czech Republic Haemate P Csl Behring (Rdna), Von Factor (Rdna) 50 I.U. /, Von Factor 120 I.U. / /Infusion Czech Republic Haemate P Csl Behring (Rdna), Von Factor (Rdna) 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Czech Republic Fanhdi Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 120 I.U. / Czech Republic Fanhdi Instituto Grifols, S.A., Von Factor 25 EMA/472578/2016 Page 21/124
22 I.U. /, Von Factor 30 I.U. / Czech Republic Fanhdi Instituto Grifols, S.A., Von Factor 50 I.U. /, Von Factor 60 I.U. / Czech Republic Octanate Octapharma (Ip) Czech Republic Octanate Octapharma (Ip)- 250 Czech Republic Octanate Octapharma (Ip)- 500 Czech Republic Wilate Octapharma (Ip)-, Von Factor 1000 EMA/472578/2016 Page 22/124
23 , Von Factor 1000 Czech Republic Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Denmark Haemate Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion Denmark Haemate Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. /Infusion EMA/472578/2016 Page 23/124
24 / Denmark Octanate Octapharma Ab 1000 Denmark Octanate Octapharma Ab 250 Denmark Octanate Octapharma Ab 500 Denmark Octanate Lv Octapharma Ab 1000 Denmark Octanate Lv Octapharma Ab 500 Denmark Wilnativ Octapharma Ab, Von Factor 1000, Von Factor 1000 EMA/472578/2016 Page 24/124
25 Denmark Wilnativ Octapharma Ab, Von Factor 500, Von Factor 500 I.U. Vial Estonia Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Estonia Immunate Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Estonia Recombinate Baxalta Innovations (Rdna) EMA/472578/2016 Page 25/124
26 (Rdna) 100 I.U. / Estonia Recombinate Baxalta Innovations (Rdna) (Rdna) 200 I.U. / Estonia Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. / Estonia Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Estonia Optivate Bio Products Laboratory 100 I.U. / Estonia Wilate Octapharma (Ip)-, Von Factor 100 I.U. /, Von Factor 100 I.U. EMA/472578/2016 Page 26/124
27 / Estonia Wilate Octapharma (Ip)-, Von Factor 100 I.U. /, Von Factor 1000 I.U. / Estonia Octanate Octapharma Ab 1000 Estonia Octanate Octapharma Ab 500 Finland Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Finland Immunate Baxalta Innovations, Von Factor 50 EMA/472578/2016 Page 27/124
28 I.U. /, Von Factor 38 I.U. / Finland Haemate Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion Finland Haemate Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Finland Octafil Octapharma Ab 1000 Finland Octafil Octapharma Ab 250 EMA/472578/2016 Page 28/124
29 Finland Octafil Octapharma Ab 500 Finland Octafil Lv Octapharma Ab 1000 Finland Octafil Lv Octapharma Ab 500 Finland Wilate Octapharma Ab, Von Factor 1000, Von Factor 1000 Finland Wilate Octapharma Ab, Von Factor 500, Von Factor 500 I.U. EMA/472578/2016 Page 29/124
30 Vial Finland Amofil Sanquin Plasma Products B.V. 100 I.U. / Powder For Solution For Finland Amofil Sanquin Plasma Products B.V. 500 I.U. / Powder For Solution For France Factane Lfb Biomedicaments 100 I.U. / France Factane Lfb Biomedicaments 200 I.U. / France Octanate Octapharma France 100 I.U. / France Octanate Octapharma France 1000 France Octanate Octapharma France EMA/472578/2016 Page 30/124
31 200 I.U. / France Octanate Octapharma France 250 France Octanate Octapharma France 500 Germany Immunate Baxalta Deutschland, Von Factor 100 I.U. /, Von Factor 60 I.U. / Germany Immunate Baxalta Deutschland, Von Factor 50 I.U. /, Von Factor 30 I.U. / Germany Recombinate Baxalta Deutschland (Rdna) EMA/472578/2016 Page 31/124
32 (Rdna) 1000 I.U. / 10 Germany Optivate Bio Products Laboratory 100 I.U. / Germany Haemoctin Sdh Biotest Pharma 100 I.U. / Germany Haemoctin Sdh Biotest Pharma 50 I.U. / Germany Beriate Csl Behring 100 I.U. / Germany Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion /Infusion Germany Haemate P Csl Behring EMA/472578/2016 Page 32/124
33 , Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Germany Fanhdi Grifols Deutschland 100 I.U. / Germany Fanhdi Grifols Deutschland 25 I.U. / Germany Fanhdi Grifols Deutschland 50 I.U. / Germany Faktor Viii Sdh Aus Plasma Vom Menschen Gewonnener Blutgerinnungsfaktor Viii Intersero Intersero 100 I.U. / Germany Faktor Viii Sdh Aus Plasma Vom Menschen Intersero 50 EMA/472578/2016 Page 33/124
34 Gewonnener Blutgerinnungsfaktor Viii Intersero I.U. / Germany Octanate Octapharma 1000 Germany Octanate Octapharma 250 Germany Octanate Octapharma 500 Germany Wilate Octapharma, Von Factor 1000, Von Factor 1000 Germany Wilate Octapharma, Von Factor 450, Von EMA/472578/2016 Page 34/124
35 Factor 400 I.U. Vial Germany Wilate Octapharma, Von Factor 500, Von Factor 500 I.U. Vial Germany Wilate Octapharma, Von Factor 900, Von Factor 800 I.U. Vial Greece Immunate Baxter Hellas, Von Factor 100 I.U. /, Von Factor 75 I.U. / Greece Immunate Baxter Hellas EMA/472578/2016 Page 35/124
36 , Von Factor 50 I.U. /, Von Factor 38 I.U. / Greece Recombinate Baxter Hellas (Rdna) (Rdna) 100 I.U. / Greece Recombinate Baxter Hellas (Rdna) (Rdna) 25 I.U. / Greece Recombinate Baxter Hellas (Rdna) (Rdna) 50 I.U. / Greece Haemate P Csl Behring Mepe, Von Factor 50 I.U. /, Von /Infusion EMA/472578/2016 Page 36/124
37 Factor 120 I.U. / Greece Haemate P Csl Behring Mepe, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Greece Fanhdi Demo Abee 100 I.U. / Greece Fanhdi Demo Abee 25 I.U. / Greece Fanhdi Demo Abee 50 I.U. / Greece Octanate Octapharma Hellas A.E Greece Octanate Octapharma Hellas A.E. EMA/472578/2016 Page 37/124
38 250 Greece Octanate Octapharma Hellas A.E. 500 Greece Wilate Octapharma Hellas A.E., Von Factor 1000, Von Factor 1000 Greece Wilate Octapharma Hellas A.E., Von Factor 500, Von Factor 500 I.U. Vial Greece Haemoctin Vianex S.A. 100 I.U. / Greece Haemoctin Vianex S.A. EMA/472578/2016 Page 38/124
39 50 I.U. / Hungary Immunate S/D Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Hungary Immunate S/D Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Hungary Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Hungary Recombinate Baxalta Innovations (Rdna) (Rdna) 200 I.U. / EMA/472578/2016 Page 39/124
40 Hungary Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Hungary Optivate Bio Products Laboratory 100 I.U. / Hungary Haemoctin Biotest Hungaria Kft. 100 I.U. / Hungary Haemoctin Biotest Hungaria Kft. 50 I.U. / Hungary Beriate Csl Behring 100 I.U. / /Infusion Hungary Beriate Csl Behring 200 I.U. / /Infusion Hungary Haemate Csl Behring, Von Factor 50 /Infusion EMA/472578/2016 Page 40/124
41 I.U. /, Von Factor 120 I.U. / Hungary Haemate Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Hungary Humaclot Bioplazma Manufacturing And Trading Llc 100 I.U. / Hungary Humaclot Bioplazma Manufacturing And Trading Llc 50 I.U. / Hungary Humafactor-8 Bioplazma Manufacturing And Trading Llc 100 I.U. / Hungary Fanhdi Instituto Grifols, S.A. 100 EMA/472578/2016 Page 41/124
42 I.U. / Hungary Fanhdi Instituto Grifols, S.A. 25 I.U. / Hungary Fanhdi Instituto Grifols, S.A. 50 I.U. / Hungary Octanate Octapharma (Ip) Hungary Octanate Octapharma (Ip)- 250 Hungary Octanate Octapharma (Ip)- 500 Hungary Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 EMA/472578/2016 Page 42/124
43 Hungary Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Iceland Obizur Baxalta Innovations 500 Units Vial Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 100 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 125 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 200 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 250 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 300 I.U. / EMA/472578/2016 Page 43/124
44 Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 400 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 50 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 500 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 600 I.U. / Iceland Advate Baxter Ag Octocog Alfa Octocog Alfa 750 I.U. / Iceland Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Iceland Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Iceland Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Iceland Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 EMA/472578/2016 Page 44/124
45 Iceland Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Iceland Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Iceland Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Iceland Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Iceland Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Iceland Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Iceland Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Iceland Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Iceland Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 EMA/472578/2016 Page 45/124
46 Iceland Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Iceland Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Iceland Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Iceland Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Iceland Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Iceland Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Iceland Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Iceland Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 125 I.U. / Iceland Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 250 I.U. / EMA/472578/2016 Page 46/124
47 Iceland Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 375 I.U. / Iceland Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 500 I.U. / Iceland Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 62.5 I.U. / Iceland Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 750 I.U. / Iceland Nuwiq Octapharma Ab (Rdna) (Rdna) 250 I.U. Vial Iceland Nuwiq Octapharma Ab (Rdna) (Rdna) 400 I.U. / Iceland Nuwiq Octapharma Ab (Rdna) (Rdna) 500 I.U. Vial EMA/472578/2016 Page 47/124
48 Iceland Nuwiq Octapharma Ab (Rdna) (Rdna) 800 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 125 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 250 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 500 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 62.5 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 125 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 250 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 500 I.U. / In Pre- Filled Syringe In Pre- Filled Syringe EMA/472578/2016 Page 48/124
49 Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 62.5 I.U. / Iceland Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 750 I.U. / Ireland Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Ireland Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. / Ireland Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Ireland Optivate Bio Products Laboratory 100 In Pre- Filled Syringe In Pre- Filled Syringe In Pre- Filled Syringe EMA/472578/2016 Page 49/124
50 I.U. / Ireland Fanhdi Instituto Grifols, S.A. 100 I.U. / Ireland Fanhdi Instituto Grifols, S.A. 25 I.U. / Ireland Fanhdi Instituto Grifols, S.A. 50 I.U. / Ireland Octanate Octapharma-Ltd 1000 Ireland Octanate Octapharma-Ltd 250 Ireland Octanate Octapharma-Ltd 500 Ireland Wilate Octapharma-Ltd, Von EMA/472578/2016 Page 50/124
51 Factor 1000, Von Factor 1000 Ireland Wilate Octapharma-Ltd, Von Factor 500, Von Factor 500 I.U. Vial Italy Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Italy Recombinate Baxalta Innovations (Rdna) (Rdna) 200 I.U. / Italy Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. EMA/472578/2016 Page 51/124
52 / Italy Recombinate Baxalta Innovations (Rdna) (Rdna) 250 I.U. / 5 Italy Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Italy Talate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Italy Talate Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Italy Haemoctin Biotest Pharma EMA/472578/2016 Page 52/124
53 100 I.U. / Italy Haemoctin Biotest Pharma 50 I.U. / Italy Beriate Csl Behring 100 I.U. / /Infusion Italy Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion Italy Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Italy Alphanate Grifols Italia S.P.A EMA/472578/2016 Page 53/124
54 , Von Factor 100 I.U. /, Von Factor 120 I.U. / Infusion Italy Alphanate Grifols Italia S.P.A, Von Factor 150 I.U. /, Von Factor 180 I.U. / Infusion Italy Alphanate Grifols Italia S.P.A, Von Factor 50 I.U. /, Von Factor 60 I.U. / Infusion Italy Fanhdi Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Infusion EMA/472578/2016 Page 54/124
55 Factor 120 I.U. / Italy Fanhdi Instituto Grifols, S.A., Von Factor 25 I.U. /, Von Factor 30 I.U. / Infusion Italy Fanhdi Instituto Grifols, S.A., Von Factor 50 I.U. /, Von Factor 60 I.U. / Infusion Italy Emoclot Kedrion S.P.A I.U. / 10 Infusion Italy Emoclot Kedrion S.P.A. 500 I.U. / 10 Infusion Italy Emowil Kedrion S.P.A. EMA/472578/2016 Page 55/124
56 1000 I.U. / 10 Infusion Italy Emowil Kedrion S.P.A. 500 I.U. / 10 Infusion Italy Klott Kedrion S.P.A I.U. / 10 Infusion Italy Klott Kedrion S.P.A. 500 I.U. / 10 Infusion Italy Octanate Octapharma Italy S.P.A Italy Octanate Octapharma Italy S.P.A. 250 Italy Octanate Octapharma Italy S.P.A. 500 EMA/472578/2016 Page 56/124
57 Italy Wilate Octapharma Italy S.P.A., Von Factor 1000, Von Factor 1000 Italy Wilate Octapharma Italy S.P.A., Von Factor 450, Von Factor 400 I.U. Vial Italy Wilate Octapharma Italy S.P.A., Von Factor 500, Von Factor 500 I.U. Vial Italy Wilate Octapharma Italy S.P.A., Von Factor 900, EMA/472578/2016 Page 57/124
58 Von Factor 800 I.U. Vial Latvia Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Latvia Immunate Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Latvia Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Latvia Recombinate Baxalta Innovations (Rdna) EMA/472578/2016 Page 58/124
59 (Rdna) 200 I.U. / Latvia Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Latvia Optivate Bio Products Laboratory 100 I.U. / Latvia Dried Bio Products Powder For Solution Fraction, Type 8y Bio Products Laboratory, Von Factor 25 I.U. /, Von Factor 26 I.U. / For Latvia Octanate Octapharma (Ip) Latvia Octanate Octapharma (Ip)- 250 Latvia Octanate Octapharma (Ip)- EMA/472578/2016 Page 59/124
60 500 Latvia Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 Latvia Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Liechtenstein Obizur Baxalta Innovations 500 Units Vial Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 100 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 125 I.U. / EMA/472578/2016 Page 60/124
61 Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 200 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 250 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 300 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 400 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 50 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 500 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 600 I.U. / Liechtenstein Advate Baxter Ag Octocog Alfa Octocog Alfa 750 I.U. / Liechtenstein Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 EMA/472578/2016 Page 61/124
62 Liechtenstein Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Liechtenstein Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Liechtenstein Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Liechtenstein Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Liechtenstein Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Liechtenstein Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Liechtenstein Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Liechtenstein Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Liechtenstein Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 EMA/472578/2016 Page 62/124
63 Liechtenstein Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Liechtenstein Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Liechtenstein Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Liechtenstein Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Liechtenstein Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Liechtenstein Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Liechtenstein Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Liechtenstein Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Liechtenstein Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 EMA/472578/2016 Page 63/124
64 Liechtenstein Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Liechtenstein Novoeight Novo Nordisk Turoctocog Alfa Turoctocog Alfa Pharma Ag 125 I.U. / Liechtenstein Novoeight Novo Nordisk Turoctocog Alfa Turoctocog Alfa Pharma Ag 250 I.U. / Liechtenstein Novoeight Novo Nordisk Turoctocog Alfa Turoctocog Alfa Pharma Ag 375 I.U. / Liechtenstein Novoeight Novo Nordisk Turoctocog Alfa Turoctocog Alfa Pharma Ag 500 I.U. / Liechtenstein Novoeight Novo Nordisk Turoctocog Alfa Turoctocog Alfa Pharma Ag 62.5 I.U. / Liechtenstein Novoeight Novo Nordisk Turoctocog Alfa Turoctocog Alfa Pharma Ag 750 I.U. / Liechtenstein Nuwiq Octapharma Ab (Rdna) (Rdna) 250 I.U. Vial Liechtenstein Nuwiq Octapharma Ab EMA/472578/2016 Page 64/124
65 (Rdna) (Rdna) 400 I.U. / Liechtenstein Nuwiq Octapharma Ab (Rdna) (Rdna) 500 I.U. Vial Liechtenstein Nuwiq Octapharma Ab (Rdna) (Rdna) 800 I.U. / Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 125 I.U. / Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 250 I.U. / Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 500 I.U. / Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 62.5 I.U. / Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog EMA/472578/2016 Page 65/124
66 Alfa 125 I.U. / In Pre- Filled Syringe Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 250 I.U. / In Pre- Filled Syringe Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 500 I.U. / In Pre- Filled Syringe Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 62.5 I.U. / In Pre- Filled Syringe Liechtenstein Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 750 I.U. / In Pre- Filled Syringe Lithuania Immunate Baxter Ag, Von Factor 100 I.U. /, Von Factor 75 I.U. / Lithuania Immunate Baxter Ag EMA/472578/2016 Page 66/124
67 , Von Factor 50 I.U. /, Von Factor 38 I.U. / Lithuania Recombinate Baxter Ag (Rdna) (Rdna) 100 I.U. / Lithuania Recombinate Baxter Ag (Rdna) (Rdna) 200 I.U. / Lithuania Recombinate Baxter Ag (Rdna) (Rdna) 50 I.U. / Lithuania Optivate Bio Products Laboratory 100 I.U. / Lithuania Haemoctin Sdh Biotest Pharma EMA/472578/2016 Page 67/124
68 100 I.U. / Lithuania Haemoctin Sdh Biotest Pharma 50 I.U. / Lithuania Octanate Octapharma (Ip) Lithuania Octanate Octapharma (Ip)- 250 Lithuania Octanate Octapharma (Ip)- 500 Lithuania Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 Lithuania Wilate Octapharma (Ip)-, Von EMA/472578/2016 Page 68/124
69 Factor 500, Von Factor 500 I.U. Vial Luxembourg Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Luxembourg Recombinate Baxalta Innovations (Rdna) (Rdna) 200 I.U. / Luxembourg Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. / Luxembourg Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Luxembourg Haemate P Csl Behring, Von EMA/472578/2016 Page 69/124
70 Factor 50 I.U. /, Von Factor 120 I.U. / Luxembourg Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / Luxembourg Factane Lfb Biomedicaments 100 I.U. / Luxembourg Octanate Octapharma Benelux S.A./N.V Luxembourg Octanate Octapharma Benelux S.A./N.V. 250 Luxembourg Octanate Octapharma Benelux S.A./N.V. /Infusion /Infusion EMA/472578/2016 Page 70/124
71 500 Luxembourg Wilate Octapharma Benelux S.A./N.V., Von Factor 100, Von Factor 100 I.U. Vial Malta Recombinate Baxalta Innovations (Rdna) (Rdna) 1000 Malta Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. / Malta Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Malta Immunate Baxter Ag, Von Factor 100 EMA/472578/2016 Page 71/124
72 I.U. /, Von Factor 75 I.U. / Malta Immunate Baxter Ag, Von Factor 50 I.U. /, Von Factor 38 I.U. / Malta Optivate Bio Products Laboratory 100 I.U. / Malta Dried Fraction, Type 8y Bio Products Bio Products Laboratory, Von Factor 25 I.U. /, Von Factor 26 I.U. / Powder For Solution For Malta Haemoctin Sdh Biotest Pharma 100 EMA/472578/2016 Page 72/124
73 I.U. / Malta Haemoctin Sdh Biotest Pharma 50 I.U. / Malta Emoclot Kedrion S.P.A I.U. / 10 Infusion Malta Octanate Octapharma (Ip) Malta Octanate Octapharma (Ip)- 250 Malta Octanate Octapharma (Ip)- 500 Malta Octanate Lv Octapharma (Ip) Malta Octanate Lv Octapharma (Ip)- EMA/472578/2016 Page 73/124
74 500 Malta Wilate Octapharma (Ip)-, Von Factor 90 I.U. /, Von Factor 80 I.U. / Netherlands Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Netherlands Immunate Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Netherlands Recombinate Baxalta Innovations (Rdna) EMA/472578/2016 Page 74/124
75 (Rdna) 100 I.U. / Netherlands Recombinate Baxalta Innovations (Rdna) (Rdna) 200 I.U. / Netherlands Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. / Netherlands Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Netherlands Optivate Bio Products Laboratory 100 I.U. / Netherlands Haemate P Csl Behring, Von Factor 50 I.U. /, Von /Infusion EMA/472578/2016 Page 75/124
76 Factor 120 I.U. / Netherlands Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Netherlands Alphanate Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 25 I.U. / Netherlands Alphanate Instituto Grifols, S.A., Von Factor 50 I.U. /, Von Factor 12.5 I.U. / Netherlands Octanate Octapharma 1000 EMA/472578/2016 Page 76/124
77 Netherlands Octanate Octapharma 250 Netherlands Octanate Octapharma 500 Netherlands Octanate Lv Octapharma 1000 Netherlands Octanate Lv Octapharma 500 Netherlands Wilate Octapharma, Von Factor 1000, Von Factor 1000 Netherlands Wilate Octapharma, Von Factor 500, EMA/472578/2016 Page 77/124
78 Von Factor 500 I.U. Vial Netherlands Aafact Sanquin Plasma Products B.V Netherlands Aafact Sanquin Plasma Products B.V. 500 Norway Obizur Baxalta Innovations 500 Units Vial Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 100 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 125 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 200 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 250 I.U. / Powder For Solution For Powder For Solution For EMA/472578/2016 Page 78/124
79 Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 300 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 400 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 50 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 500 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 600 I.U. / Norway Advate Baxter Ag Octocog Alfa Octocog Alfa 750 I.U. / Norway Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Norway Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Norway Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 EMA/472578/2016 Page 79/124
80 Norway Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Norway Helixate Nexgen Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Norway Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Norway Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Norway Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Norway Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Norway Iblias Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Norway Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Norway Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 EMA/472578/2016 Page 80/124
81 Norway Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Norway Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Norway Kogenate Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Norway Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 1000 I.U. / 2.5 Norway Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 2000 I.U. / 5 Norway Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 250 I.U. / 2.5 Norway Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 3000 I.U. / 5 Norway Kovaltry Bayer Pharma Ag Octocog Alfa Octocog Alfa 500 I.U. / 2.5 Norway Haemate Csl Behring (Rdna), Von /Infusion EMA/472578/2016 Page 81/124
82 Factor (Rdna) 50 I.U. /, Von Factor 120 I.U. / Norway Haemate Csl Behring (Rdna), Von Factor (Rdna) 66.6 I.U. /, Von Factor 160 I.U. / Norway Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 125 I.U. / Norway Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 250 I.U. / Norway Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 375 I.U. / Norway Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 500 I.U. / Norway Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 62.5 I.U. / /Infusion EMA/472578/2016 Page 82/124
83 Norway Novoeight Novo Nordisk A/S Turoctocog Alfa Turoctocog Alfa 750 I.U. / Norway Nuwiq Octapharma Ab (Rdna) (Rdna) 250 I.U. Vial Norway Nuwiq Octapharma Ab (Rdna) (Rdna) 400 I.U. / Norway Nuwiq Octapharma Ab (Rdna) (Rdna) 500 I.U. Vial Norway Nuwiq Octapharma Ab (Rdna) (Rdna) 800 I.U. / Norway Octanate Octapharma Ag 250 EMA/472578/2016 Page 83/124
84 Norway Wilate Octapharma Ag, Von Factor 1000, Von Factor 1000 Norway Wilate Octapharma Ag, Von Factor 500, Von Factor 500 I.U. Vial Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 125 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 250 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 500 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 62.5 I.U. / EMA/472578/2016 Page 84/124
85 Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 125 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 250 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 500 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 62.5 I.U. / Norway Refacto Af Pfizer Limited Moroctocog Alfa Moroctocog Alfa 750 I.U. / Poland Immunate Baxter Polska Sp Z O.O., Von Factor 100 I.U. /, Von Factor 75 I.U. / In Pre- Filled Syringe In Pre- Filled Syringe In Pre- Filled Syringe In Pre- Filled Syringe In Pre- Filled Syringe EMA/472578/2016 Page 85/124
86 Poland Immunate Baxter Polska Sp Z O.O., Von Factor 50 I.U. /, Von Factor 38 I.U. / Poland Recombinate Baxter Polska Sp Z O.O. (Rdna) (Rdna) 100 I.U. / Poland Recombinate Baxter Polska Sp Z O.O. (Rdna) (Rdna) 200 I.U. / Poland Recombinate Baxter Polska Sp Z O.O. (Rdna) (Rdna) 50 I.U. / Poland Optivate Bio Products Laboratory 100 I.U. / Poland Innovate Biomed-Lublin EMA/472578/2016 Page 86/124
87 Wsisz S.A I.U. / Poland Haemoctin Biotest Pharma 100 I.U. / Poland Haemoctin Biotest Pharma 50 I.U. / Poland Beriate Csl Behring 100 I.U. / Poland Beriate Csl Behring 200 I.U. / Poland Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion /Infusion /Infusion Poland Haemate P Csl Behring EMA/472578/2016 Page 87/124
88 , Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Poland Fanhdi Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 120 I.U. / /Infusion Poland Fanhdi Instituto Grifols, S.A., Von Factor 25 I.U. /, Von Factor 30 I.U. / /Infusion Poland Fanhdi Instituto Grifols, S.A., Von Factor 50 I.U. /, Von /Infusion EMA/472578/2016 Page 88/124
89 Factor 60 I.U. / Poland Emoclot Kedrion S.P.A I.U. / 10 Infusion Poland Emoclot Kedrion S.P.A. 500 I.U. / 10 Infusion Poland Octanate Octapharma (Ip) Poland Octanate Octapharma (Ip)- 250 Poland Octanate Octapharma (Ip)- 500 Poland Octanate Lv Octapharma (Ip) EMA/472578/2016 Page 89/124
90 Poland Octanate Lv Octapharma (Ip)- 500 Poland Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 Poland Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Portugal Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / EMA/472578/2016 Page 90/124
91 Portugal Immunate Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Portugal Optivate Bio Products Laboratory 100 I.U. / Portugal Haemoctin Biotest Pharma 100 I.U. / Portugal Haemoctin Biotest Pharma 50 I.U. / Portugal Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / EMA/472578/2016 Page 91/124
92 Portugal Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / Portugal Beriate Csl Behring 100 I.U. / /Infusion Portugal Fanhdi Instituto Grifols, S.A. 100 I.U. / Portugal Fanhdi Instituto Grifols, S.A. 25 I.U. / Portugal Fanhdi Instituto Grifols, S.A. 50 I.U. / Portugal Emoclot D.I. Kedrion S.P.A I.U. / 10 Infusion EMA/472578/2016 Page 92/124
93 Portugal Emoclot D.I. Kedrion S.P.A. 500 I.U. / 10 Infusion Portugal Factane Lfb Biomedicaments 100 I.U. / Portugal Octanate Octapharma Produtos Farmaceuticos, Lda Portugal Octanate Octapharma Produtos Farmaceuticos, Lda. 250 Portugal Octanate Octapharma Produtos Farmaceuticos, Lda. 500 Portugal Octanate Lv Octapharma Produtos Farmaceuticos, Lda Portugal Octanate Lv Octapharma Produtos Farmaceuticos, Lda. 500 EMA/472578/2016 Page 93/124
94 Portugal Wilate Octapharma Produtos Farmaceuticos, Lda., Von Factor 1000, Von Factor 1000 Portugal Wilate Octapharma Produtos Farmaceuticos, Lda., Von Factor 500, Von Factor 500 I.U. Vial Romania Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Romania Immunate Baxalta Innovations, Von Factor 50 I.U. /, EMA/472578/2016 Page 94/124
95 Von Factor 38 I.U. / Romania Recombinate Baxalta Innovations (Rdna) (Rdna) 100 I.U. / Romania Recombinate Baxalta Innovations (Rdna) (Rdna) 200 I.U. / Romania Recombinate Baxalta Innovations (Rdna) (Rdna) 25 I.U. / Romania Recombinate Baxalta Innovations (Rdna) (Rdna) 50 I.U. / Romania Optivate Bio Products Laboratory 100 I.U. / EMA/472578/2016 Page 95/124
96 Romania Haemoctin Sdh Biotest Pharma 100 I.U. / Romania Haemoctin Sdh Biotest Pharma 50 I.U. / Romania Beriate Csl Behring 100 I.U. / /Infusion Romania Beriate Csl Behring 200 I.U. / /Infusion Romania Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / /Infusion Romania Haemate P Csl Behring, Von Factor 66.6 I.U. /, /Infusion EMA/472578/2016 Page 96/124
97 Von Factor 160 I.U. / Romania Fanhdi Instituto Grifols, S.A. 100 I.U. / Romania Fanhdi Instituto Grifols, S.A. 25 I.U. / Romania Fanhdi Instituto Grifols, S.A. 50 I.U. / Romania Emoclot Kedrion S.P.A. 500 I.U. / 10 Infusion Romania Octanate Octapharma (Ip) Romania Octanate Octapharma (Ip)- 250 EMA/472578/2016 Page 97/124
98 Romania Octanate Octapharma (Ip)- 500 Romania Octanate Lv Octapharma (Ip) Romania Octanate Lv Octapharma (Ip)- 500 Romania Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 Romania Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial EMA/472578/2016 Page 98/124
99 Slovakia Immunate Baxalta Innovations, Von Factor 100 I.U. /, Von Factor 75 I.U. / Slovakia Immunate Baxalta Innovations, Von Factor 50 I.U. /, Von Factor 38 I.U. / Slovakia Recombinate Baxter Ag (Rdna) (Rdna) 100 I.U. / Slovakia Recombinate Baxter Ag (Rdna) (Rdna) 25 I.U. / Slovakia Recombinate Baxter Ag (Rdna) EMA/472578/2016 Page 99/124
100 (Rdna) 50 I.U. / Slovakia Optivate Bio Products Laboratory 100 I.U. / Slovakia Beriate Csl Behring 100 I.U. / /Infusion Slovakia Beriate Csl Behring 200 I.U. / /Infusion Slovakia Haemate P Csl Behring (Rdna), Von Factor (Rdna) 50 I.U. /, Von Factor 120 I.U. / /Infusion Slovakia Haemate P Csl Behring (Rdna), Von Factor (Rdna) 66.6 I.U. /, /Infusion EMA/472578/2016 Page 100/124
101 Von Factor 160 I.U. / Slovakia Fanhdi Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 120 I.U. / Slovakia Fanhdi Instituto Grifols, S.A., Von Factor 25 I.U. /, Von Factor 30 I.U. / Slovakia Fanhdi Instituto Grifols, S.A., Von Factor 50 I.U. /, Von Factor 60 I.U. / EMA/472578/2016 Page 101/124
102 Slovakia Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 Slovakia Wilate Octapharma (Ip)-, Von Factor 450, Von Factor 400 I.U. Vial Slovakia Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Slovakia Wilate Octapharma (Ip)-, Von Factor 900, EMA/472578/2016 Page 102/124
103 Von Factor 800 I.U. Vial Slovakia Octanate Octapharma Pharmazeutika Produktionsgesmbh 1000 Slovakia Octanate Octapharma Pharmazeutika Produktionsgesmbh 250 Slovakia Octanate Octapharma Pharmazeutika Produktionsgesmbh 500 Slovenia Beriate Csl Behring 100 I.U. / /Infusion Slovenia Haemate P Csl Behring (Rdna), Von Factor (Rdna) 50 I.U. /, Von Factor 120 I.U. / /Infusion EMA/472578/2016 Page 103/124
104 Slovenia Octanate Octapharma (Ip) Slovenia Octanate Octapharma (Ip)- 250 Slovenia Octanate Octapharma (Ip)- 500 Slovenia Octanate Kons Octapharma (Ip) Slovenia Octanate Kons Octapharma (Ip)- 500 Slovenia Wilate Octapharma (Ip)-, Von Factor 1000, Von Factor 1000 EMA/472578/2016 Page 104/124
105 Slovenia Wilate Octapharma (Ip)-, Von Factor 500, Von Factor 500 I.U. Vial Spain Haemoctin Biotest Pharma 100 I.U. / Spain Haemoctin Biotest Pharma 50 I.U. / Spain Beriate Csl Behring 100 I.U. / /Infusion Spain Beriate Csl Behring 200 I.U. / /Infusion Spain Haemate P Csl Behring, S.A, Von Factor 50 I.U. /, Von /Infusion EMA/472578/2016 Page 105/124
106 Factor 120 I.U. / Spain Haemate P Csl Behring, S.A, Von Factor 66.6 I.U. /, Von Factor 160 I.U. / /Infusion Spain Fanhdi Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 120 I.U. / Spain Fanhdi Instituto Grifols, S.A., Von Factor 25 I.U. /, Von Factor 30 I.U. / Spain Fanhdi Instituto Grifols, S.A., Von EMA/472578/2016 Page 106/124
107 Factor 50 I.U. /, Von Factor 60 I.U. / Spain Octanate Octapharma S.A Spain Octanate Octapharma S.A. 250 Spain Octanate Octapharma S.A. 500 Spain Octanate Lv Octapharma S.A Spain Octanate Lv Octapharma S.A. 500 Spain Wilate Octapharma S.A., Von EMA/472578/2016 Page 107/124
108 Factor 100 I.U. /, Von Factor 100 I.U. / Spain Wilate Octapharma S.A., Von Factor 500, Von Factor 500 I.U. Vial Sweden Immunate Baxalta Innovations 100 I.U. / Sweden Immunate Baxalta Innovations 50 I.U. / Sweden Haemate Csl Behring, Von Factor 50 I.U. /, Von /Infusion EMA/472578/2016 Page 108/124
109 Factor 120 I.U. / Sweden Haemate Csl Behring, Von Factor 67 I.U. /, Von Factor 160 I.U. / /Infusion Sweden Octanate Octapharma Ab 1000 Sweden Octanate Octapharma Ab 250 Sweden Octanate Octapharma Ab 500 Sweden Octanate Lv Octapharma Ab 1000 Sweden Octanate Lv Octapharma Ab EMA/472578/2016 Page 109/124
110 500 Sweden Wilate Octapharma Ab, Von Factor 1000, Von Factor 1000 Sweden Wilate Octapharma Ab, Von Factor 500, Von Factor 500 I.U. Vial United Kingdom Optivate Bio Products Laboratory 100 I.U. / United Kingdom Optivate Bio Products Laboratory I.U. / Powder For Solution United Kingdom 8y Bio Products Laboratory, Von Powder For Solution For EMA/472578/2016 Page 110/124
111 Factor 25 I.U. /, Von Factor 26 I.U. / United Kingdom Haemoctin Biotest Pharma 100 I.U. / United Kingdom Haemoctin Biotest Pharma 50 I.U. / United Kingdom Haemate P Csl Behring, Von Factor 50 I.U. /, Von Factor 120 I.U. / United Kingdom Haemate P Csl Behring, Von Factor 66.6 I.U. /, Von /Infusion /Infusion EMA/472578/2016 Page 111/124
112 Factor 160 I.U. / United Kingdom Fanhdi Instituto Grifols, S.A. 100 I.U. / United Kingdom Fanhdi Instituto Grifols, S.A. 25 I.U. / United Kingdom Fanhdi Instituto Grifols, S.A. 50 I.U. / United Kingdom Alphanate Instituto Grifols, S.A., Von Factor 100 I.U. /, Von Factor 120 I.U. / Powder For United Kingdom Alphanate Instituto Grifols, S.A., Von Factor 150 I.U. /, Von Powder For EMA/472578/2016 Page 112/124
113 Factor 180 I.U. / United Kingdom Alphanate Instituto Grifols, S.A., Von Factor 50 I.U. /, Von Factor 60 I.U. / Powder For United Kingdom Octanate Octapharma-Ltd 1000 United Kingdom Octanate Octapharma-Ltd 250 United Kingdom Octanate Octapharma-Ltd 500 United Kingdom Octanate Lv Octapharma-Ltd 1000 United Kingdom Octanate Lv Octapharma-Ltd EMA/472578/2016 Page 113/124
114 500 United Kingdom Wilate Octapharma-Ltd, Von Factor 1000, Von Factor 1000 United Kingdom Wilate Octapharma-Ltd, Von Factor 500, Von Factor 500 I.U. Vial Centrally authorised products MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/03/271/001 Advate 250 IU Powder and powder: vial (glass); solvent: vial (glass) 1 vial + 1 vial + reconstitution device EMA/472578/2016 Page 114/124
115 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/03/271/002 Advate 500 IU Powder and EU/1/03/271/003 Advate 1000 IU Powder and EU/1/03/271/004 Advate 1500 IU Powder and EU/1/03/271/005 Advate 2000 IU Powder and EU/1/03/271/006 Advate 3000 IU Powder and EU/1/03/271/007 Advate 250 IU Powder and EU/1/03/271/008 Advate 500 IU Powder and EU/1/03/271/009 Advate 1000 IU Powder and EU/1/03/271/010 Advate 1500 IU Powder and EU/1/03/271/011 Advate 250 IU Powder and EU/1/03/271/012 Advate 500 IU Powder and EU/1/03/271/013 Advate 1000 IU Powder and powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial + reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device EMA/472578/2016 Page 115/124
116 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/03/271/014 Advate 1500 IU Powder and EU/1/03/271/015 Advate 2000 IU Powder and EU/1/03/271/016 Advate 3000 IU Powder and EU/1/03/271/017 Advate 250 IU Powder and EU/1/03/271/018 Advate 500 IU Powder and EU/1/03/271/019 Advate 1000 IU Powder and EU/1/03/271/020 Advate 1500 IU Powder and powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device 1 vial + 1 vial preassembled with reconstitution device MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1046/001 ELOCTA 250 IU Powder and EU/1/15/1046/002 ELOCTA 500 IU Powder and Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) 1 vial (powder) + 1 pre-filled syringe (solvent) 1 vial (powder) + 1 pre-filled syringe (solvent) EMA/472578/2016 Page 116/124
117 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1046/003 ELOCTA 750 IU Powder and EU/1/15/1046/004 ELOCTA 1000 IU Powder and EU/1/15/1046/005 ELOCTA 1500 IU Powder and EU/1/15/1046/006 ELOCTA 2000 IU Powder and EU/1/15/1046/007 ELOCTA 3000 IU Powder and Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) 1 vial (powder) + 1 pre-filled syringe (solvent) 1 vial (powder) + 1 pre-filled syringe (solvent) 1 vial (powder) + 1 pre-filled syringe (solvent) 1 vial (powder) + 1 pre-filled syringe (solvent) 1 vial (powder) + 1 pre-filled syringe (solvent) EMA/472578/2016 Page 117/124
118 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/00/144/001 Helixate NexGen 250 IU Powder and EU/1/00/144/002 Helixate NexGen 500 IU Powder and EU/1/00/144/003 Helixate NexGen 1000 IU Powder and EU/1/00/144/004 Helixate NexGen 2000 IU Powder and EU/1/00/144/005 Helixate NexGen 3000 IU Powder and powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) 1 vial + 1 vial + 1 filter transfer + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer + 1 venipuncture set + 1 syringe + 2 swabs MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1077/001 Iblias 250 IU Powder and EU/1/15/1077/002 Iblias 500 IU Powder and EU/1/15/1077/003 Iblias 1000 IU Powder and EU/1/15/1077/004 Iblias 2000 IU Powder and EU/1/15/1077/005 Iblias 3000 IU Powder and powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) 1 vial + 1 vial + 1 filter transfer device + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer device + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer device + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer device + 1 venipuncture set + 1 syringe + 2 swabs 1 vial + 1 vial + 1 filter transfer device + 1 venipuncture set + 1 syringe + 2 swabs EMA/472578/2016 Page 118/124
119 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/00/143/004 KOGENATE Bayer 250 IU Powder and EU/1/00/143/005 KOGENATE Bayer 500 IU Powder and EU/1/00/143/006 KOGENATE Bayer 1000 IU Powder and EU/1/00/143/007 KOGENATE Bayer 250 IU Powder and EU/1/00/143/008 KOGENATE Bayer 500 IU Powder and EU/1/00/143/009 KOGENATE Bayer 1000 IU Powder and EU/1/00/143/010 KOGENATE Bayer 2000 IU Powder and EU/1/00/143/011 KOGENATE Bayer 2000 IU Powder and powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) 1 vial + 1 Bio-Set device + 1 prefilled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 Bio-Set device + 1 prefilled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 Bio-Set device + 1 prefilled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 Bio-Set device + 1 prefilled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set + 4 swabs + 2 plasters EMA/472578/2016 Page 119/124
120 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/00/143/012 KOGENATE Bayer 3000 IU Powder and EU/1/00/143/013 KOGENATE Bayer 3000 IU Powder and powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) 1 vial + 1 Bio-Set device + 1 prefilled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters 1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set + 4 swabs + 2 plasters MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1076/001 Kovaltry 250 IU Powder and EU/1/15/1076/002 Kovaltry 250 IU Powder and EU/1/15/1076/003 Kovaltry 500 IU Powder and EU/1/15/1076/004 Kovaltry 500 IU Powder and EU/1/15/1076/005 Kovaltry 1000 IU Powder and EU/1/15/1076/006 Kovaltry 1000 IU Powder and powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) 1 vial with reconstitution cap + 1 pre-filled syringe (3 ml) + 1 venipuncture set 1 vial + 1 pre-filled syringe (3 ml) + 1 vial adapter + 1 venipuncture set 1 vial with reconstitution cap + 1 pre-filled syringe (3 ml) + 1 venipuncture set 1 vial + 1 pre-filled syringe (3 ml) + 1 vial adapter + 1 venipuncture set 1 vial with reconstitution cap + 1 pre-filled syringe (3 ml) + 1 venipuncture set 1 vial + 1 pre-filled syringe (3 ml) + 1 vial adapter + 1 venipuncture set EMA/472578/2016 Page 120/124
121 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1076/007 Kovaltry 2000 IU Powder and EU/1/15/1076/008 Kovaltry 2000 IU Powder and EU/1/15/1076/009 Kovaltry 3000 IU Powder and EU/1/15/1076/010 Kovaltry 3000 IU Powder and powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) powder: vial (glass); solvent: pre-filled syringe (glass) 1 vial with reconstitution cap + 1 pre-filled syringe (5 ml) + 1 venipuncture set 1 vial + 1 pre-filled syringe (5 ml) + 1 vial adapter + 1 venipuncture set 1 vial with reconstitution cap + 1 pre-filled syringe (5 ml) + 1 venipuncture set 1 vial + 1 pre-filled syringe (5 ml) + 1 vial adapter + 1 venipuncture set MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/13/888/001 NovoEight 250 IU Powder and EU/1/13/888/002 NovoEight 500 IU Powder and EU/1/13/888/003 NovoEight 1000 IU Powder and EU/1/13/888/004 NovoEight 1500 IU Powder and EU/1/13/888/005 NovoEight 2000 IU Powder and vial (glass) 1 vial + 1 pre-filled syringe + 1 vial adapter vial (glass) 1 vial + 1 pre-filled syringe + 1 vial adapter vial (glass) 1 vial + 1 pre-filled syringe + 1 vial adapter vial (glass) 1 vial + 1 pre-filled syringe + 1 vial adapter vial (glass) 1 vial + 1 pre-filled syringe + 1 vial adapter EMA/472578/2016 Page 121/124
122 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/13/888/006 NovoEight 3000 IU Powder and vial (glass) 1 vial + 1 pre-filled syringe + 1 vial adapter MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/14/936/001 Nuwiq 250 IU Powder and EU/1/14/936/002 Nuwiq 500 IU Powder and EU/1/14/936/003 Nuwiq 1000 IU Powder and EU/1/14/936/004 Nuwiq 2000 IU Powder and Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) Powder: vial (glass); Solvent: pre-filled syringe (glass) 1 vial (powder) + 1 pre-filled syringe (solvent) + 1 vial adapter 1 vial (powder) + 1 pre-filled syringe (solvent) + 1 vial adapter 1 vial (powder) + 1 pre-filled syringe (solvent) + 1 vial adapter 1 vial (powder) + 1 pre-filled syringe (solvent) + 1 vial adapter MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1035/001 Obizur 500 U Powder and solution for solution for injection vial (glass) 1 vial EMA/472578/2016 Page 122/124
123 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/15/1035/002 Obizur 500 U Powder and solution for solution for injection EU/1/15/1035/003 Obizur 500 U Powder and solution for solution for injection vial (glass) 5 vials vial (glass) 10 vials MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/99/103/001 ReFacto AF 250 IU Powder and EU/1/99/103/002 ReFacto AF 500 IU Powder and EU/1/99/103/003 ReFacto AF 1000 IU Powder and EU/1/99/103/004 ReFacto AF 2000 IU Powder and EU/1/99/103/005 ReFacto AF 3000 IU Powder and EU/1/99/103/006 ReFacto AF 500 IU Powder and EU/1/99/103/007 ReFacto AF 1000 IU Powder and powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder: vial (glass); solvent: vial (glass) powder and solvent: prefilled syringe (glass) powder and solvent: prefilled syringe (glass) powder and solvent: prefilled syringe (glass) 1 vial +1 pre-filled syringe + 1 injection kit 1 vial +1 pre-filled syringe + 1 injection kit 1 vial +1 pre-filled syringe + 1 injection kit 1 vial +1 pre-filled syringe + 1 injection kit 1 pre-filled syringe + 1 injection kit 1 pre-filled syringe + 1 injection kit 1 pre-filled syringe + 1 injection kit EMA/472578/2016 Page 123/124
124 MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/99/103/008 ReFacto AF 2000 IU Powder and EU/1/99/103/009 ReFacto AF 250 IU Powder and powder and solvent: prefilled syringe (glass) powder and solvent: prefilled syringe (glass) 1 pre-filled syringe + 1 injection kit 1 pre-filled syringe + 1 injection kit MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Pack size EU/1/13/857/001 Voncento 250 IU / 600 IU EU/1/13/857/002 Voncento 500 IU / 1200 IU EU/1/13/857/003 Voncento 500 IU / 1200 IU EU/1/13/857/004 Voncento 1000 IU / 2400 IU Powder and for injection/infusion Powder and for injection/infusion Powder and for injection/infusion Powder and for injection/infusion powder: vial (glass) + solvent: vial (glass) powder: vial (glass) + solvent: vial (glass) powder: vial (glass) + solvent: vial (glass) powder: vial (glass) + solvent: vial (glass) 1 vial + 1 vial 1 vial + 1 vial 1 vial + 1 vial 1 vial + 1 vial EMA/472578/2016 Page 124/124
List of nationally authorised medicinal products
9 July 2015 EMA/483660/2015 Procedure Management and Committees Support Active substance: diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate
ERASMUS+ MASTER LOANS
ERASMUS+ MASTER LOANS Erasmus+ Master Loan: opening up access to more affordable lending for cross-border studies The Erasmus+ programme makes it possible for students who want to take a full Masters level
The Guardianship Service
The Guardianship Service How can they help you? When you arrive in Belgium Are you under the age of 18 and have you arrived in Belgium without your father or mother? You are searching for support and accommodation
NEW PASSENGER CAR REGISTRATIONS BY ALTERNATIVE FUEL TYPE IN THE EUROPEAN UNION 1 Quarter 4 2015
NEW PASSENGER CAR REGISTRATIONS BY ALTERNATIVE FUEL TYPE IN THE Quarter 4 2015 Alternative fuel vehicle (AFV) registrations: +20.0% in 2015; +21.1% in Q4 In the fourth quarter of 2015, total alternative
ERASMUS+ MASTER LOANS
Ref. Ares(2015)660570-17/02/2015 ERASMUS+ MASTER LOANS Erasmus+ Master Loan: opening up access to more affordable lending for cross-border studies The Erasmus+ programme makes it possible for students
Energy prices in the EU Household electricity prices in the EU rose by 2.9% in 2014 Gas prices up by 2.0% in the EU
92/2015-27 May 2015 Energy prices in the EU Household electricity prices in the EU rose by 2.9% in 2014 Gas prices up by 2.0% in the EU In the European Union (EU), household electricity prices 1 rose by
1. Perception of the Bancruptcy System... 2. 2. Perception of In-court Reorganisation... 4
Bankruptcy Systems and In-court Reorganisation of Firms, 2010 Content: 1. Perception of the Bancruptcy System... 2 2. Perception of In-court Reorganisation... 4 3. Perception of Creditor Committees, Fast
Labour Force Survey 2014 Almost 10 million part-time workers in the EU would have preferred to work more Two-thirds were women
75/2015-27 April 2015 Labour Force Survey 2014 Almost 10 million part-time workers in the EU would have preferred to work more Two-thirds were women Among the 44.1 million persons in the European Union
Employee eligibility to work in the UK
Employee eligibility to work in the UK This document details legal requirements that apply to ALL new members of staff All employers in the UK are legally bound to comply with the Asylum and Immigration
COMMUNICATION FROM THE COMMISSION
EUROPEAN COMMISSION Brussels, 17.9.2014 C(2014) 6767 final COMMUNICATION FROM THE COMMISSION Updating of data used to calculate lump sum and penalty payments to be proposed by the Commission to the Court
Credit transfer to Customer account with AS "Meridian Trade Bank" EUR, USD free of charge * - 4.1.2. Other countries currency information in the Bank
Pricelist for individuals residents of Latvia SERVICES 4. TRANSFERS In the Bank PRICE LIST IN EUR Using «MultiNet» 4.1. 4.1.1. Credit transfer to Customer account with EUR, USD free of charge * 4.1.2.
The European regulatory system for medicines and the European Medicines Agency
The European regulatory system for medicines and the European Medicines Agency A consistent approach to medicines regulation across the European Union An agency of the European Union This booklet is intended
International Hints and Tips
International Hints and Tips Content Q: What is the cut off time for processing International payments? A: International payments must be submitted and fully approved within the cut off time indicated
Keeping European Consumers safe Rapid Alert System for dangerous non-food products 2014
Keeping European Consumers safe Rapid Alert System for dangerous non-food products 2014 COMPLETE STATISTICS Justice and Consumers Directorate-General for Justice and Consumers Directorate Consumers Unit
41 T Korea, Rep. 52.3. 42 T Netherlands 51.4. 43 T Japan 51.1. 44 E Bulgaria 51.1. 45 T Argentina 50.8. 46 T Czech Republic 50.4. 47 T Greece 50.
Overall Results Climate Change Performance Index 2012 Table 1 Rank Country Score** Partial Score Tendency Trend Level Policy 1* Rank Country Score** Partial Score Tendency Trend Level Policy 21 - Egypt***
187/2014-5 December 2014. EU28, euro area and United States GDP growth rates % change over the previous quarter
187/2014-5 December 2014 This News Release has been revised following an error in the data for Gross Fixed Capital Formation. This affects both the growth of GFCF and its contribution to GDP growth. All
99/2015-9 June 2015. EU28, euro area and United States GDP growth rates % change over the previous quarter
2005Q1 2005Q2 2005Q3 2005Q4 2006Q1 2006Q2 2006Q3 2006Q4 2007Q1 2007Q2 2007Q3 2007Q4 2008Q1 2008Q2 2008Q3 2008Q4 2009Q1 2009Q2 2009Q3 2009Q4 2010Q1 2010Q2 2010Q3 2010Q4 2011Q1 2011Q2 2011Q3 2011Q4 2012Q1
European Research Council
ERC Advanced Grants 2011 Outcome: Indicative Statistics Reproduction is authorised provided that the source ERC is acknowledged NB: In these graphs grantee refers to a candidate selected for ERC funding
Planned Healthcare in Europe for Lothian residents
Planned Healthcare in Europe for Lothian residents Introduction This leaflet explains what funding you may be entitled to if you normally live in Lothian (Edinburgh, West Lothian, Midlothian and East Lothian
ENTERING THE EU BORDERS & VISAS THE SCHENGEN AREA OF FREE MOVEMENT. EU Schengen States. Non-Schengen EU States. Non-EU Schengen States.
ENTERING THE EU BORDERS & VISAS THE SCHENGEN AREA OF FREE MOVEMENT An area without internal borders where EU citizens and non-eu nationals may move freely EU Schengen States Non-Schengen EU States IS Azores
ERASMUS+ MASTER LOANS
ERASMUS+ MASTER LOANS Erasmus+ Master Loan: opening up access to more affordable lending for cross-border studies The Erasmus+ programme makes it possible for students who want to take a full Master's-level
168/2014-4 November 2014. At risk of poverty or social exclusion 2 rate in the EU28, 2008-2013 (% of total population)
168/2014-4 November 2014 At risk of poverty or social exclusion in the EU28 More than 120 million persons at risk of poverty or social exclusion in 2013 Almost 1 out of every 4 persons in the EU in this
SURVEY ON THE TRAINING OF GENERAL CARE NURSES IN THE EUROPEAN UNION. The current minimum training requirements for general care nurses
SURVEY ON THE TRAINING OF GENERAL CARE NURSES IN THE EUROPEAN UNION This survey serves as a background document for the discussion of the Commission's legislative proposal to modernize the minimum requirements
Analysis of statistics 2015
Analysis of statistics 215 January 216 ECHR Analysis of Statistics 215 Table of Contents Overview of the Court s statistics in 215... 4 A. Number of new applications... 4 B. Applications disposed of judicially
GfK PURCHASING POWER INTERNATIONAL
GfK PURCHASING POWER INTERNATIONAL 1 Agenda 1. Europe 3 2. Americas 45 3. Asia & Near East 54 4. Afrika 66 5. Australia 68 6. Overview of countries and available levels 70 2 2 EUROPE 4 GfK
Family benefits Information about health insurance country. Udbetaling Danmark Kongens Vænge 8 3400 Hillerød. A. Personal data
Mail to Udbetaling Danmark Kongens Vænge 8 3400 Hillerød Family benefits Information about health insurance country A. Personal data Name Danish civil registration (CPR) number Address Telephone number
Size and Development of the Shadow Economy of 31 European and 5 other OECD Countries from 2003 to 2015: Different Developments
January 20, 2015 ShadEcEurope31_January2015.doc Size and Development of the Shadow Economy of 31 European and 5 other OECD Countries from 2003 to 2015: Different Developments by Friedrich Schneider *)
European Research Council
ERC Starting Grant Outcome: Indicative statistics Reproduction is authorised provided the source ERC is acknowledged ERCEA/JH. ERC Starting Grant: call Submitted and selected proposals by domain Submitted
Alcohol Consumption in Ireland 1986-2006 A Report for the Health Service Executive
Alcohol Consumption in Ireland 1986-2006 A Report for the Health Service Executive Prepared by Dr. Ann Hope This report should be referenced: Hope, A. (2007). Alcohol consumption in Ireland 1986-2006.
Product name Strength Pharmaceutical form. 100/6 micrograms per actuation. Formodual 100/6 Mikrogramm/Sprüh stoß, Druckgasinhalation, Lösung
Annex I List of the names, pharmaceutical, strength of the medicinal products, route of, marketing authorisation holders in the member states 1 Belgium Bulgaria Cyprus Denmark Estonia Finland 100/6 Mikrogramm/Sprüh
Erasmus+ International Cooperation
International Cooperation Work together with European higher education institutions ? The EU's programme to support education, training youth & sport Funding for programmes, projects & scholarships Fosters
SEPA. Changes in the Payment System Implementation of the European SEPA Regulations for Kuna and Euro Payments
SEPA Changes in the Payment System Implementation of the European SEPA Regulations for Kuna and Euro Payments SEPA The Single Euro Payments Area (SEPA) stands for a European Union (EU) payments integration
Waste. Copenhagen, 3 rd September 2014. Almut Reichel Project Manager Sustainable consumption and production & waste, European Environment Agency
Waste Copenhagen, 3 rd September 2014 Almut Reichel Project Manager Sustainable consumption and production & waste, European Environment Agency Waste and material resources MAWP Strategic Area 1.9 Objective
193/2014-15 December 2014. Hourly labour costs in the EU28 Member States, 2012 (in )
193/2014-15 December 2014 Labour Cost Survey 2012 in the EU28 Labour costs highest in the financial and insurance sector Three times higher than in the accommodation and food sector In 2012, average hourly
Taxation trends in the European Union EU27 tax ratio fell to 39.3% of GDP in 2008 Steady decline in top corporate income tax rate since 2000
DG TAXUD 95/2010-28 June 2010 Taxation trends in the European Union EU27 tax ratio fell to 39.3% of GDP in 2008 Steady decline in top corporate income tax rate since 2000 The overall tax-to-gdp ratio 1
Our patent and trade mark attorneys are here to help you protect and profit from your ideas, making sure they re working every bit as hard as you do.
Our patent and trade mark attorneys are here to help you protect and profit from your ideas, making sure they re working every bit as hard as you do. Our people work with everyone from multi-nationals
CO2 BASED MOTOR VEHICLE TAXES IN THE EU IN 2015
CO2 BASED MOTOR VEHICLE TAXES IN THE EU IN 2015 COUNTRY AT (AUSTRIA) BE (BELGIUM) BG (BULGARIA) CO2/FUEL CONSUMPTION TAXES A fuel consumption tax (Normverbrauchsabgabe or NoVA) is levied upon the first
C h a r t 1 - KPNQwest Group
C h a r t 1 - Group NV BIJLAGE / ANNEX 1 IP Services BV Services Finance BV financing moratorium: 30-05 bankruptcy: 25-09 09-2002 Assets Central Europe BV moratorium: 18-06 moratorium has ended Netherlands
EUF STATISTICS. 31 December 2013
. ESTIMATES OF EU TURNOVER VOLUMES. Turnover volumes by product, allocation and notification (Estimates of EU s, Millions of ) Estimate of the EU % on Turnover Significance of the sample on total turnover
Carer s Allowance and Carer s Credit
Carer s Allowance and Carer s Credit Benefit and support you may get if you are caring for someone 2 Introduction This leaflet: explains what Carer s Allowance and Carer s Credit are asks some questions
EBA REPORT ON THE BENCHMARKING OF DIVERSITY PRACTICES. EBA-Op-2016-10 08 July 2016
EBA REPORT ON THE BENCHMARKING OF DIVERSITY PRACTICES EBA-Op-2016-10 08 July 2016 BENCHMARKING OF DIVERSITY PRACTICES AT THE EU LEVEL Benchmarking of diversity practices at the European Union level List
Chase Online SM Wire Transfer Help Guide page 1 of 16. How to Send Wire Transfers on Chase Online SM
Chase Online SM Wire Transfer Help Guide page 1 of 16 How to Send Wire Transfers on Chase Online SM For a convenient, secure and quick way to send money directly to someone s bank account, use a wire transfer
Cash machine withdrawal in the EU (+Norway and Iceland)
Cash machine withdrawal in the EU (+Norway and Iceland) Country Is it free of charge to go to a cash machine from a different bank than consumers own to withdraw money? If withdrawal is not free of charge,
Mutual recognition between the EU member states: official framework for collaboration saves resources?
Mutual recognition between the EU member states: official framework for collaboration saves resources? Alar Irs, Estonia Pre-ICDRA meeting, Nov 28-29, 2010 Effective collaboration: the future for medicines
Application Form: Receptionist / PA to the Senior Leadership Team
Application Form: Receptionist / PA to the Senior Leadership Team This application form is written in BLACK ink. Please answer the questions in dark blue and return electronically to Lesley Starkes, Finance
Finnish foreign trade 2014 Figures and diagrams. 27.2.2015 FINNISH CUSTOMS Statistics 1
Finnish foreign trade 214 Figures and diagrams 27.2.215 FINNISH CUSTOMS Statistics 1 IMPORTS, EXPORTS AND TRADE BALANCE 199-214 7 billion e 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9
INTERNATIONAL TRACKED POSTAGE SERVICE
INTERNATIONAL TRACKED POSTAGE SERVICE Index Expanding Internationally...03 The Post NL Service...04 How it works... 05 Post NL Rates...06 Transit times...07 Customer Service...08 Expanding Internationally
13 th Economic Trends Survey of the Architects Council of Europe
13 th Economic Trends Survey 13 th Economic Trends Survey of the Architects Council of Europe 13 th Economic Trends Survey Breakdown of responses COUNTRY ANSWERS France 1464 Belgium 399 Spain 365 Italy
Applying for Pension from Abroad. Did you know that you can apply for a pension even for work you did abroad in the 1960s?
Applying for Pension from Abroad Did you know that you can apply for a pension even for work you did abroad in the 1960s? The Finnish Centre for Pensions is at your service when you apply for a pension
RULES FOR THE REIMBURSEMENT OF TRAVEL AND SUBSISTENCE EXPENSES FOR EXCHANGE OF OFFICIALS
EUROPEAN COMMISSION CONSUMERS, HEALTH AND FOOD EXECUTIVE AGENCY Consumers and Food Safety Unit RULES FOR THE REIMBURSEMENT OF TRAVEL AND SUBSISTENCE EXPENSES FOR EXCHANGE OF OFFICIALS CONSUMER PROGRAMME
THE ORGANISATION AND FINANCING OF HEALTH CARE SYSTEM IN LATVIA
THE ORGANISATION AND FINANCING OF HEALTH CARE SYSTEM IN LATVIA Eriks Mikitis Ministry of Health of the Republic of Latvia Department of Health Care Director General facts, financial resources Ministry
ERMInE Database. Presentation by Nils Flatabø SINTEF Energy Research. ERMInE Workshop 2 - Northern Europe Oslo, 1. November 2006
ERMInE Database Presentation by Nils Flatabø SINTEF Energy Research ERMInE Workshop 2 - Northern Europe Oslo, 1. November 26 Overview Content of the Ermine Database Electronic Questionnaire RTD&D Data
Health care in Scotland for UK passport holders living abroad
Health care in Scotland for UK passport holders living abroad If you have a UK passport and you live abroad, this factsheet tells you how you can get health care from the NHS when you are in Scotland.
CCBE LAWYERS STATISTICS 2015 Total n of women lawyer members of the Bar Austria 31/12/2014 5.940 1.210 80
Austria 31/12/2014 5.940 1.210 80 Belgium (OBFG) 01/12/2014 7.756 Pas de statistiques par sexe Belgium (OVB) 01/12/2014 10.418 (5.907 male s + 24 on B-list; 4.472 s + 15 on B-list). 4.472 s + 15 on B-list
W I R E T R A N S F E R S E R V I C E S
Move money quickly and easily through Chase Commercial Online s Wire Transfers service. 1 Select U.S. dollars or another eligible currency to wire funds to most domestic or international recipients. Add
1. Name of pharmacopoeia
1 1. Name of pharmacopoeia European Pharmacopoeia 36 Member states (Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece,
Computing our Future Computer programming and coding in schools in Europe. Anja Balanskat, Senior Manager European Schoolnet
Computing our Future Computer programming and coding in schools in Europe Anja Balanskat, Senior Manager European Schoolnet ABOUT THE SURVEY What do Ministries currently think about the topic? Curricula
2. Is registration with PARAFES free? Yes.
Automated Border Control 1. What does PARAFES stand for? PARAFES (translated from French) means Automated Fast Track Crossing at External Schengen Borders. 2. Is registration with PARAFES free? Yes. 3.
DRAFT AMENDING BUDGET N 6 TO THE GENERAL BUDGET 2014 GENERAL STATEMENT OF REVENUE
EUROPEAN COMMISSION Brussels, 17.10.2014 COM(2014) 649 final DRAFT AMENDING BUDGET N 6 TO THE GENERAL BUDGET 2014 GENERAL STATEMENT OF REVENUE STATEMENT OF EXPENDITURE BY SECTION Section III Commission
3 Year: Year of the submission of the ingredient information.
1 2 Footnotes to Table 3 Name of Manufacturer or Importer: This information is submitted by Philip Morris Products S.A., which owns the relevant intellectual property rights of Philip Morris International
Exercise 39. The Euro. At the end of this exercise you will:
Exercise 39 The Euro At the end of this exercise you will: Know how the Euro was named Know the countries using the Euro Be able to name all the Euro notes Be able to name all the Euro coins Be able to
Implementing the cooperation mechanisms of the RES directive current status and open questions
Implementing the cooperation mechanisms of the RES directive current status and open questions Corinna Klessmann, Ecofys Germany RE-SHAPING Workshop, Vilnius, 16.05.2011 Supported by Intelligent Energy
Equity Release Schemes in the European Union
Reifner Clerc-Renaud Perez-Carillo Tiffe Knobloch Equity Release Schemes in the European Union institut fur finanzdienstleistungen e.v. Contents PREFACE I EXECUTIVE SUMMARY V TABLES XXIX FIGURES XXX 1.
OVERVIEW OF PURCHASE AND TAX INCENTIVES FOR ELECTRIC VEHICLES IN THE EU
01.04.2014 OVERVIEW OF PURCHASE AND TAX INCENTIVES FOR ELECTRIC VEHICLES IN THE EU This table provides an overview of the incentives that are granted in the Member States of the European Union for the
CONTENTS --------------------------------------------------------------------------------------
en WiFi USB DONGLE CONTENTS -------------------------------------------------------------------------------------- 9 SAFETY AND SET-UP 10 WiFi USB DONGLE 10 Packing contents 10 Special features 10 Connection
Replacement Migration
Population Division Department of Economic and Social Affairs United Nations Secretariat Replacement Migration United Nations ST/ESA/SER.A/206 Population Division Department of Economic and Social Affairs
EN ISO 14121-1. Safety of machinery Risk assessment. Sicherheit von Maschinen Risikobeurteilung Teil 1: Leitsätze (ISO 14121-1:2007)
ÖNORM EN ISO 14121-1 Edition: 2008-01-01 Safety of machinery Risk assessment Part 1: Principles (ISO 14121-1:2007) Sicherheit von Maschinen Risikobeurteilung Teil 1: Leitsätze (ISO 14121-1:2007) Sécurité
Funding and network opportunities for cluster internationalization
BSR Innovation Express: Cluster- to- Cluster Conference Funding and network opportunities for cluster internationalization Jens Peter Vittrup Special Adviser Email: [email protected] Why international R&I cooperation?
Customers who don t want to get tied down by a contract can choose the O 2 go Prepaid option, which gives them a daily Internet flat rate of up to 1 G
28 September 2011 O 2 go: New data tariffs without contract duration and more speed New postpaid and prepaid surf flat rates from 15 euros O 2 go without contract duration and basic fee Mobile data now
FUSIONS Food waste data set for EU-28. New Estimates and Environmental Impact
FUSIONS Food waste data set for EU-28 New Estimates and Environmental Impact 15 October 2015 Food waste is an issue of importance to global food security and good environmental governance, directly linked
CO2 BASED MOTOR VEHICLE TAXES IN THE EU IN 2016
CO2 BASED MOTOR VEHICLE TAXES IN THE EU IN 2016 AUSTRIA A fuel consumption tax (Normverbrauchsabgabe or NoVA) is levied upon the first registration of a passenger car. It is calculated as follows: (CO2
Beer statistics. 2014 edition. The Brewers of Europe
Beer statistics 2014 edition The Brewers of Europe Beer statistics 2014 edition The Brewers of Europe Editor: Marlies Van de Walle 1st edition, October 2014 ISBN 978-2-9601382-3-8 EAN 9782960138238 1
General information about the bank
GENERAL LIST OF PRICES AND SERVICES May 2014 General information about the bank I. Bank name and address Varengold Bank AG Große Elbstraße 27 22767 Hamburg Also referred to as "Varengold" or "bank" in
Attendance Allowance. Benefit and support you may get if you are ill or disabled and aged 65 or over
Attendance Allowance Benefit and support you may get if you are ill or disabled and aged 65 or over 2 Attendance Allowance Introduction This leaflet: explains what Attendance Allowance is asks some questions
EU Lesson Plan. Name of Teacher: Sharon Goralewski School: Oakland Schools Title of Lesson Plan: The European Union: United in Diversity
EU Lesson Plan Name of Teacher: School: Oakland Schools Title of Lesson Plan: The European Union: United in Diversity Grades: 6th or 7 th Description: This lesson introduces the students to the countries
Dublin, March 2013. EPSO Network of Experts in the field of Personnel Selection 14th March 2013
Dublin, March 2013 EPSO Network of Experts in the field of Personnel Selection 14th March 2013 On-going and upcoming competitions AD2012 by Citizenship AD2012 Citizenship %EU Population validated application
in Scotland for holidaymakers from overseas
in Scotland for holidaymakers from overseas In Scotland, most health care is provided by the National Health Service (NHS). If you are coming to Scotland on holiday or to visit friends or relatives, you
FEDERATION EUROPEENNE DE LA MANUTENTION Product Group. industrial trucks. A brief guide for identification of noncompliant. - Exhaust Emission -
FEDERATION EUROPEENNE DE LA MANUTENTION Product Group Industrial Trucks FEM A brief guide for identification of noncompliant industrial trucks 11.2010 (E) - Exhaust Emission - I n d e x 1 Introduction...
CENTRAL BANK OF CYPRUS
APPENDIX 2 NOTIFICATION BY A BANK INCORPORATED IN CYPRUS, WHICH WISHES TO PROVIDE SERVICES, ON A CROSS BORDER BASIS, IN OTHER EUROPEAN UNION (E.U.) MEMBER STATES IN ACCORDANCE WITH ARTICLE (28) OF THE
About us. As our customer you will be able to take advantage of the following benefits: One Provider. Flexible Billing. Our Portal.
About us At RoamingExpert we specialise in mobile roaming tariffs which are tailored to the specific needs of the yachting industry. Our unique offering generates significant savings when compared to standard
Comprehensive emissions per capita for industrialised countries
THE AUSTRALIA INSTITUTE Comprehensive emissions per capita for industrialised countries Hal Turton and Clive Hamilton The Australia Institute September 2001 the Parties included in Annex I shall implement
First estimate for 2014 Euro area international trade in goods surplus 194.8 bn 24.2 bn surplus for EU28
30/2015-16 February 2015 First estimate for 2014 Euro area international trade in goods surplus 194.8 bn 24.2 bn surplus for EU28 The first estimate for the euro area 1 (EA18) trade in goods balance with
How To Calculate Tax Burden In European Union
The Tax Burden of Typical Workers in the EU 28 2015 James Rogers Cécile Philippe Institut Économique Molinari, Paris Bruxelles TABLE OF CONTENTS Abstract 2 Background 2 Main Results 3 On average, a respite
TPI: Traffic Psychology International on a common European curriculum for postgraduate education in traffic psychology
TPI: Traffic Psychology International on a common European curriculum for postgraduate education in traffic psychology Sucha, M.*, Sramkova, L.** DeVol, D.* * TPI - Traffic Psychology International **
AMADEUS: Analyse MAjor Databases from EUropean Sources - A financial database of 4 million European companies, including Eastern Europe MODULE.
AMADEUS http://amadeus.bvdep.com/ip AMADEUS: Analyse MAjor Databases from EUropean Sources - A financial database of 4 million European companies, including Eastern Europe MODULE. General AMADEUS contains
PLAN PRICE GUIDE 74.99. Allowance 50GB Data, unlimited minutes, unlimited texts, inclusive Roaming in selected countries 1,2, 200 084
PLAN PRICE GUIDE Pay Monthly For new and upgrading customers from 27th April 2016 EE Complete 24 month plans 74.99 79.99 84.99 Allowance 50GB Data, unlimited minutes, unlimited texts, inclusive Roaming
IN AN EMERGENCY / 2016
PEUGEOT OPEN EUROPE Assistance 24/24 7/7 From France: 01 47 89 24 24 From abroad: +33 1 47 89 24 24 IN AN EMERGENCY / 2016 www.peugeot-openeurope.com CONTENTS / 2016 WHAT TO DO IN CASE OF BREAKDOWN, ACCIDENT,
your own success? Locate addresses exactly Visualise your company data Analyse connections Make the right decisions Use your full potential
PTV MAP&MARKET BASIC How can you map out your own success? Locate addresses exactly Visualise your company data Analyse connections Make the right decisions Use your full potential A unique combination
Single Euro Payments Area
Single Euro Payments Area Overview SEPA (Single Euro Payments Area) is a European payments initiative which aims to create one single, integrated, standardised payments market in Europe. It is an area
How To Make A Positive Decision On Asylum Applications In 2014
82/2015-12 May 2015 Asylum decisions in the EU EU Member States granted to more than 185 000 asylum seekers in 2014 Syrians remain the main beneficiaries This News Release has been revised on 21 May following
Proposal from the Philippines for amendments to the Kyoto Protocol
UNITED NATIONS Distr. GENERAL FCCC/KP/CMP/2009/5 12 June 2009 Original: ENGLISH CONFERENCE OF THE PARTIES SERVING AS THE MEETING OF THE PARTIES TO THE KYOTO PROTOCOL Fifth session Copenhagen, 7 18 December
TOYOTA I_SITE More than fleet management
EMPOWERING YOUR BUSINESS TOYOTA I_SITE More than fleet management www.toyota-forklifts.eu TOYOTA I_SITE More than fleet management Toyota I_Site is a unique combination of technology, information, expertise
Statistical Data on Women Entrepreneurs in Europe
Statistical Data on Women Entrepreneurs in Europe September 2014 Enterprise and Industry EUROPEAN COMMISSION Directorate-General for Enterprise and Industry Directorate D SMEs and Entrepreneurship Unit
International ACH: Payment Gateway to Europe
International ACH: Payment Gateway to Europe Treasury Symposium St. Petersburg Florida Tuesday, January 27 Concurrent Session 16 10:15am 11:30am International ACH: Payment Gateway to Europe Presenters:
Adobe Public Relations (PR) Guidelines
Adobe Public Relations (PR) Guidelines Adobe Partner Connection Reseller Program and Adobe Partner Connection Distributor Program Thank you for participating in the Adobe Partner Connection Reseller or
